RADIOTHERAPY AND CTLA-4 BLOCKADE EXPAND ANTITUMOR T CELLS DIFFERENTIATION STATES AND COOPERATE WITH CD40 AGONIST TO INDUCE TUMOR REJECTION

被引：0
|
作者：
Rudqvist, Nils [1 ]
Lhuillier, Claire [1 ]
Charpentier, Maud [1 ]
Wennerberg, Erik [1 ]
Spada, Sheila [1 ]
Sheridan, Caroline [1 ]
Zhou, Xi Kathy [1 ]
Zhang, Tuo [1 ]
Sims, Jennifer [2 ]
Alonso, Alicia [1 ]
Demaria, Sandra [1 ]
机构：
[1] Weill Cornell Med, Houston, TX USA
[2] Mem Sloan Kettering Canc Ctr, Tarrytown, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
465
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
  • [1] Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells
    Rudqvist, Nils-Petter
    Pilones, Karsten A.
    Lhuillier, Claire
    Wennerberg, Erik
    Sidhom, John-William
    Emerson, Ryan O.
    Robins, Harlan S.
    Schneck, Jonathan
    Formenti, Silvia C.
    Demaria, Sandra
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (02) : 139 - 150
  • [2] Defining the TCR repertoire and functional differentiation of tumor-infiltrating T cells in mice responding to radiotherapy and CTLA-4 blockade
    Rudqvist, Nils-Petter
    Lhullier, Claire
    Wennerberg, Erik
    Sims, Jennifer
    Demaria, Sandra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Ibrutinib in combination with agonist αOX40 mAb and CTLA-4 blockade induces Eomeshi CD8 T cells and promotes tumor regression
    Emerson, Dana
    Mcnamara, Michael
    Hilgart-Martiszus, Ian
    Farhad, Mohammad
    Redmond, William
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Combination of agonist anti-OX40 therapy with CTLA-4 blockade augments anti-tumor effector CD4 and CD8 T cells
    Redmond, William
    Linch, Stefanie
    Kasiewicz, Melissa
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [5] Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
    Bajor, David L.
    Mick, Rosemarie
    Riese, Matthew J.
    Huang, Alex C.
    Sullivan, Brendan
    Richman, Lee P.
    Torigian, Drew A.
    George, Sangeeth M.
    Stelekati, Erietta
    Chen, Fang
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Xu, Xiaowei
    Wherry, E. John
    Gangadhar, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Vonderheide, Robert H.
    ONCOIMMUNOLOGY, 2018, 7 (10):
  • [6] CD28/CTLA-4/B7 and CD40/CD40L costimulation and activation of regulatory T cells
    Isabel T Vogel
    Stefaan W Van Gool
    Jan L Ceuppens
    World Journal of Immunology, 2014, 4 (02) : 63 - 77
  • [7] CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
    Bossio, Sabrina N.
    Abrate, Carolina
    Boari, Jimena Tosello
    Rodriguez, Constanza
    Canale, Fernando P.
    Ramello, Maria C.
    Brunotto, Valentina
    Richer, Wilfrid
    Rocha, Dario
    Sedlik, Christine
    Vincent-Salomon, Anne
    Borcoman, Edith
    Del Castillo, Andres
    Gruppi, Adriana
    Fernandez, Elmer
    Rodriguez, Eva V. Acosta V.
    Piaggio, Eliane
    Montes, Carolina L.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [8] NK cells and CD8+T cells cooperate to improve therapeutic responses in melanoma treated with CTLA-4 blockade and IL-2
    Kohlhapp, Frederick
    Broucek, Joseph
    Hughes, Tasha
    Huelsmann, Erica
    Zloza, Andrew
    Kaufman, Howard
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [9] Blockade of CTLA-4 Decreases the Generation of Multifunctional Memory CD4+ T Cells In Vivo
    Rudolph, Marion
    Hebel, Katrin
    Miyamura, Yoshinori
    Maverakis, Emanual
    Brunner-Weinzierl, Monika C.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (10): : 5580 - 5589
  • [10] CD40 engagement ablates CTLA-4 expression on Th40 effector cells: a mechanism for breach of tolerance
    Wagner, David
    Carter, Jessica
    Vaitaitis, Gisela
    Waid, Dan
    JOURNAL OF IMMUNOLOGY, 2011, 186
12345